Nano-X Imaging (NNOX) GM Ofir Koren details option and RSU holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Nano-X Imaging Ltd. executive Ofir Koren, General Manager of the ARC Division, filed an initial ownership report showing direct holdings of ordinary shares and stock options. The filing lists stock options over 100,000, 25,000 and 33,500 ordinary shares with exercise prices of $49.6800, $17.6300 and $11.5200, expiring between 2031 and 2033. It also describes restricted share units granted in April 2024 and February 2026, which vest over time in scheduled installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Koren Ofir
Role
General Manager, ARC Division
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy ordinary shares) — 100,000 shares (Direct);
Ordinary shares — 10,000 shares (Direct)
Footnotes (1)
- The ordinary shares reported in this row consist of the remaining unsold shares underlying 20,000 restricted share units ("RSUs") that were granted to the Reporting Person on April 16, 2024 and that vest in 16 equal quarterly installments of 6.25% each (1,250 RSUs) on each three-month anniversary of the grant date, such that all RSUs reported in this row will be exercisable by the four-year anniversary of the grant date (April 16, 2028). The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on February 5, 2026, of which 50% vest on the 12-month anniversary of the grant date and the remaining 50% vest on the 24-month anniversary of the grant date. The options reported in this row were granted to the Reporting Person by the Issuer on January 18, 2021 and are fully vested and exercisable as of the date of this report. 4. The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (March 28, 2026). 5. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).
FAQ
What does Nano-X Imaging (NNOX) Form 3 for Ofir Koren report?
The Form 3 reports Ofir Koren’s initial ownership in Nano-X Imaging, including ordinary shares, stock options over 158,500 underlying shares, and time-based restricted share units that vest over several years according to specified schedules.
How many Nano-X Imaging (NNOX) options does Ofir Koren hold?
Ofir Koren holds stock options linked to 100,000, 25,000 and 33,500 Nano-X ordinary shares. These options have exercise prices of $49.6800, $17.6300 and $11.5200 and expire between January 2031 and May 2033.
Are there buy or sell transactions in Nano-X Imaging (NNOX) Form 3 for Ofir Koren?
The Form 3 functions as an initial ownership statement. It lists holdings of ordinary shares, options and RSUs for Ofir Koren, rather than reporting open-market purchases or sales, which would typically appear on later Forms 4 or 5.